Anbio Biotechnology (NNNN), a developer of in vitro diagnostics, has filed to raise around $9M through a U.S. initial public ...
Anbio Biotechnology (NNNN) has filed to raise $8.8 million in an IPO of its Class A ordinary shares, according to an SEC F-1 registration statement. NNNN provides in vitro diagnostics products for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback